VistaGen Therapeutics, Inc.
VTGN
$3.60
-$0.83-18.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -62.24M | -55.78M | -51.42M | -47.30M | -39.57M |
| Total Depreciation and Amortization | 681.00K | 653.00K | 635.00K | 616.00K | 598.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.56M | 3.58M | 3.93M | 3.62M | 3.15M |
| Change in Net Operating Assets | 5.05M | 1.47M | 4.76M | 4.05M | 2.33M |
| Cash from Operations | -52.95M | -50.07M | -42.10M | -39.02M | -33.49M |
| Capital Expenditure | -213.00K | -214.00K | -191.00K | -132.00K | -164.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -564.00K | -8.26M | -12.96M | -13.57M | -13.15M |
| Cash from Investing | -777.00K | -8.47M | -13.15M | -13.70M | -13.31M |
| Total Debt Issued | 1.02M | 1.02M | -- | -- | -- |
| Total Debt Repaid | -364.00K | -90.00K | -- | 0.00 | 1.00K |
| Issuance of Common Stock | 31.61M | 3.68M | 3.21M | 1.26M | 93.82M |
| Repurchase of Common Stock | -- | -- | -- | -380.00K | -380.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 32.26M | 4.61M | 3.21M | 879.00K | 93.44M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.46M | -53.93M | -52.04M | -51.85M | 46.64M |